February 1973

Dextran 40 and Thromboembolism in Total Hip Replacement Surgery

Author Affiliations

New York
From the Department of Orthopedic Surgery, College of Physicians and Surgeons, Columbia-Presbyterian Medical Center, and the New York Orthopedic Hospital, New York. Dr. Rothermel is now at the Naval Hospital, Orlando, Fla.

Arch Surg. 1973;106(2):135-137. doi:10.1001/archsurg.1973.01350140003003

Sixty patients selected randomly were given dextran 40 after total hip replacement, 500 ml each day for three days, and then on alternate days until the seventh to 14th day. No effect on morbidity from thromboembolic diseases was observed in them as compared with sixty control patients randomly selected in a similar fashion and not receiving dextran.